| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.PNPBP.2006.06.013 |
| P698 | PubMed publication ID | 16863675 |
| P50 | author | Katsuaki Suzuki | Q38802292 |
| Kenji J. Tsuchiya | Q39968217 | ||
| Toshiro Sugiyama | Q40327399 | ||
| Hideo Matsuzaki | Q63150509 | ||
| Kenji Hashimoto | Q70911404 | ||
| Kazuhiko Nakamura | Q90179045 | ||
| Masaomi Iyo | Q92098561 | ||
| Yoshimoto Sekine | Q114535230 | ||
| Yasuhide Iwata | Q114535249 | ||
| Yoshio Minabe | Q114535269 | ||
| Nori Takei | Q114535294 | ||
| Masayoshi Kawai | Q114535296 | ||
| Shiro Suda | Q117194438 | ||
| Gen-Ichi Sugihara | Q117194447 | ||
| P2093 | author name string | Masatsugu Tsujii | |
| Norio Mori | |||
| Atsuko Shinohe | |||
| P433 | issue | 8 | |
| P921 | main subject | autism | Q38404 |
| P304 | page(s) | 1472-1477 | |
| P577 | publication date | 2006-07-24 | |
| P1433 | published in | Progress in Neuro-Psychopharmacology & Biological Psychiatry | Q15616665 |
| P1476 | title | Increased serum levels of glutamate in adult patients with autism | |
| P478 | volume | 30 |
| Q50344674 | A Proton Magnetic Resonance Spectroscopic Study in Autism Spectrum Disorder Using a 3-Tesla Clinical Magnetic Resonance Imaging (MRI) System: The Anterior Cingulate Cortex and the Left Cerebellum |
| Q27320751 | A computational perspective on autism |
| Q37022453 | A randomized controlled pilot trial of oral N-acetylcysteine in children with autism |
| Q42052543 | Age-related decreased inhibitory vs. excitatory gene expression in the adult autistic brain |
| Q28477358 | Alteration of plasma glutamate and glutamine levels in children with high-functioning autism |
| Q46568974 | Altered amino acid excretion in children with autism |
| Q90197293 | An association study of severity of intellectual disability with peripheral biomarkers of disabled children in a rehabilitation home, Kolkata, India |
| Q35625886 | An open-label naturalistic pilot study of acamprosate in youth with autistic disorder |
| Q59263464 | Analysis of amino acids in autism spectrum disorders |
| Q89537222 | Assessments of Amino Acids, Ammonia and Oxidative Stress Among Cohort of Egyptian Autistic Children: Correlations with Electroencephalogram and Disease Severity |
| Q37030110 | Autism spectrum disorder in children born preterm-role of exposure to perinatal inflammation |
| Q37166261 | Autism-specific copy number variants further implicate the phosphatidylinositol signaling pathway and the glutamatergic synapse in the etiology of the disorder. |
| Q31015147 | Biochemistry of the cingulate cortex in autism: An MR spectroscopy study. |
| Q36070784 | Blood Glutamate Levels in Autism Spectrum Disorder: A Systematic Review and Meta-Analysis |
| Q38816381 | Body fluid levels of neuroactive amino acids in autism spectrum disorders: a review of the literature. |
| Q26748761 | Clinical and Neurobiological Relevance of Current Animal Models of Autism Spectrum Disorders |
| Q34939651 | Common genetic variation in the GAD1 gene and the entire family of DLX homeobox genes and autism spectrum disorders |
| Q40310423 | Could fever and neuroinflammation play a role in the neurobiology of autism? A subject worthy of more research |
| Q58781462 | Decreased Serum Glutamate Levels in Male Adults with Internet Gaming Disorder: A Pilot Study |
| Q47663697 | Decreased plasma agmatine levels in autistic subjects |
| Q27025683 | Developing Medications Targeting Glutamatergic Dysfunction in Autism: Progress to Date |
| Q38122448 | Developing new pharmacotherapies for autism. |
| Q50310146 | Distinct plasma profile of polar neutral amino acids, leucine, and glutamate in children with Autism Spectrum Disorders |
| Q42106652 | Dog bites man or man bites dog? The enigma of the amino acid conjugations |
| Q38906741 | Dysfunction of sensory oscillations in Autism Spectrum Disorder |
| Q36727667 | Early pharmacological treatment of autism: a rationale for developmental treatment |
| Q36123660 | Elevated glutamatergic compounds in pregenual anterior cingulate in pediatric autism spectrum disorder demonstrated by 1H MRS and 1H MRSI. |
| Q38052081 | Excitotoxicity in the pathogenesis of autism. |
| Q38086129 | Exploring the multifactorial nature of autism through computational systems biology: calcium and the Rho GTPase RAC1 under the spotlight |
| Q37208148 | Family-Based Association Testing of OCD-associated SNPs of SLC1A1 in an autism sample |
| Q35770888 | GABA system dysfunction in autism and related disorders: from synapse to symptoms |
| Q34568690 | GABAergic/glutamatergic imbalance relative to excessive neuroinflammation in autism spectrum disorders |
| Q50312813 | Glutamate receptor 6 gene (GluR6 or GRIK2) polymorphisms in the Indian population: a genetic association study on autism spectrum disorder |
| Q38184927 | Glutamatergic candidate genes in autism spectrum disorder: an overview |
| Q55079878 | Immunoexcitotoxicity as the central mechanism of etiopathology and treatment of autism spectrum disorders: A possible role of fluoride and aluminum. |
| Q34777549 | In vivo 1H-magnetic resonance spectroscopy study of the attentional networks in autism |
| Q26828983 | Increased glutamate and homocysteine and decreased glutamine levels in autism: a review and strategies for future studies of amino acids in autism |
| Q36632136 | Increased glutamate concentration in the auditory cortex of persons with autism and first-degree relatives: a (1)H-MRS study |
| Q35549713 | Investigation of the serum levels of anterior pituitary hormones in male children with autism |
| Q30552723 | Low-dose thyroxine attenuates autism-associated adverse effects of fetal alcohol in male offspring's social behavior and hippocampal gene expression. |
| Q44452474 | Male-specific alteration in excitatory post-synaptic development and social interaction in pre-natal valproic acid exposure model of autism spectrum disorder |
| Q27315912 | Mapping autism risk loci using genetic linkage and chromosomal rearrangements |
| Q33701158 | Marked elevation of adrenal steroids, especially androgens, in saliva of prepubertal autistic children |
| Q27014201 | Medical treatment overview: traditional and novel psycho-pharmacological and complementary and alternative medications |
| Q45419983 | Memantine as adjunctive treatment to risperidone in children with autistic disorder: a randomized, double-blind, placebo-controlled trial. |
| Q37498858 | Metabolic mapping of deep brain structures and associations with symptomatology in autism spectrum disorders |
| Q91535393 | Metabolome signature of autism in the human prefrontal cortex |
| Q28544817 | Metabolomics as a tool for discovery of biomarkers of autism spectrum disorder in the blood plasma of children |
| Q49854632 | Metabotropic glutamate receptor 5 tracer [18F]-FPEB displays increased binding potential in postcentral gyrus and cerebellum of male individuals with autism: a pilot PET study. |
| Q38268023 | Multidisciplinary assessment and treatment of self-injurious behavior in autism spectrum disorder and intellectual disability: integration of psychological and biological theory and approach |
| Q39269008 | Neurobiological bases of autism-epilepsy comorbidity: a focus on excitation/inhibition imbalance |
| Q48116100 | Non-invasive evaluation of the GABAergic/glutamatergic system in autistic patients observed by MEGA-editing proton MR spectroscopy using a clinical 3 tesla instrument |
| Q50310961 | Nuclear factor kappa B may increase insight into the management of neuroinflammation and excitotoxicity in autism |
| Q36409596 | Overview of Glutamatergic Dysregulation in Central Pathologies |
| Q33390364 | Prefrontal cortex glutamate correlates with mental perspective-taking |
| Q30593705 | Proton magnetic resonance spectroscopy as a probe into the pathophysiology of autism spectrum disorders (ASD): a review. |
| Q34105312 | RECENT DEVELOPMENTS IN NEUROPATHOLOGY OF AUTISM SPECTRUM DISORDERS. |
| Q48110361 | Relationship between absolute and relative ratios of glutamate, glutamine and GABA and severity of autism spectrum disorder |
| Q44127880 | Riluzole as an adjunctive therapy to risperidone for the treatment of irritability in children with autistic disorder: a double-blind, placebo-controlled, randomized trial |
| Q48043375 | Serum amino acid profile in patients with Parkinson's disease |
| Q41173126 | Shifting brain inhibitory balance and connectivity of the prefrontal cortex of adults with autism spectrum disorder. |
| Q42407155 | Targeting neurotensin as a potential novel approach for the treatment of autism |
| Q50313366 | Targeting of glycine site on NMDA receptor as a possible new strategy for autism treatment |
| Q26738652 | The Broad Autism (Endo)Phenotype: Neurostructural and Neurofunctional Correlates in Parents of Individuals with Autism Spectrum Disorders |
| Q27500386 | The Intense World Theory – A Unifying Theory of the Neurobiology of Autism |
| Q28388719 | The dynamics of autism spectrum disorders: how neurotoxic compounds and neurotransmitters interact |
| Q38162501 | The need for a comprehensive molecular characterization of autism spectrum disorders |
| Q36027303 | The potential role of the antioxidant and detoxification properties of glutathione in autism spectrum disorders: a systematic review and meta-analysis |
| Q26998975 | The role of glutamate and its receptors in autism and the use of glutamate receptor antagonists in treatment |
| Q37559828 | The role of ionotropic glutamate receptors in childhood neurodevelopmental disorders: autism spectrum disorders and fragile x syndrome. |
| Q30474736 | Transient and steady-state auditory gamma-band responses in first-degree relatives of people with autism spectrum disorder. |
| Q50313274 | c-Kit+ cells transplantation as a new treatment for autism, a novel hypothesis with important research and clinical implication |
| Q38046662 | mGluR antagonists and GABA agonists as novel pharmacological agents for the treatment of autism spectrum disorders |
| Q26830642 | γ-band abnormalities as markers of autism spectrum disorders |
Search more.